Contact Us: 01282 426380
KM Financial Solutions | Alzheimer’s drug approved by UK regulator but too costly for NHS
124732
post-template-default,single,single-post,postid-124732,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Alzheimer’s drug approved by UK regulator but too costly for NHS

21 Aug Alzheimer’s drug approved by UK regulator but too costly for NHS

Posted at 11:18h in News by
0 Likes
Spending watchdog declines to give green light to lecanemab for patients in England
No Comments

Sorry, the comment form is closed at this time.